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a b s t r a c t
The purpose of this study was to review the outcome of dialysis-dependent patients
undergoing cardiac surgery. We retrospectively reviewed 36 dialysis-dependent patients
with a mean age of 63  9.4 years who underwent cardiac operations. Surgery included
coronary artery bypass grafting (CABG) in 27 patients (75%), valve surgery in 2 (5.5%),
combined CABG plus valve surgery in 5 (13.8%), combined valve surgery and MAZE procedure
in 1 patient, combined valve surgery, CABG and MAZE procedure in 1 patient, major aortic
surgery in 1 patient, suture of injured right ventricle in 1 patient and extirpation of infected
right atrial thrombus in 1 patient. In-hospital mortality rate was 11.1%. All the deaths
occurred in patients who underwent urgent procedure. Two of the deaths occurred in
patients who underwent cardiac surgery procedure on pump (ascending aorta replacement
and infected thrombus removing), one death occurred in a patient who underwent suture of
injured right ventricle and another one death occurred in patient who underwent the
conventional myocardial revascularization. The survival was 77.8% at 1 year. Generally
suggested predictors of increased late mortality are heart failure, urgent/emergent surgery,
the complexity of the surgical procedures (valve surgery, combined CABG, valve and major
aortic surgery) and postoperative low cardiac output syndrome. In dialysis-dependent
patients, CABG has an acceptable risk. Results in patients affected by valve lesions associ-
ated or not with coronary artery disease are improved by an early referral to surgery, before
the onset of symptoms of heart failure.
# 2015 The Czech Society of Cardiology. Published by Elsevier Sp. z o.o. All rights
reserved.
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.Introduction
Patients with end-stage renal disease (ESRD) are at high risk of
cardiovascular disease and cardiac complications, resulting in
higher rates of mortality than in the general population [1].* Corresponding author at  : Department of Cardiac Surgery, Palacky U      
Republic. Tel.: +420 58 585 2344.
E-mail address: a.klvacek@email.cz (A. Klváček).
http://dx.doi.org/10.1016/j.crvasa.2015.03.004
0010-8650/# 2015 The Czech Society of Cardiology. Published by ElseAdvancements in dialysis treatments have resulted in a
progressive increase in the prevalence of people living with
ESRD. The 5-year survival rate for patients with ESRD has
increased and the mean age has increased also [2].
Cardiovascular diseases and cardiac complications are the
major causes of death in patients with ESRD [3]. Patients withniversity Teaching Hospital, I.P. Pavlova 6, 77900 Olomouc, Czech        
vier Sp. z o.o. All rights reserved..
Table 1 – Demographic and pre-operative clinical char-
acteristics.
Variables Number of patients
Gender
Male 22
Female 14
Hypertension 27
Diabetes 17
History of smoking 15
COPD 4
Hypercholesterolemia 12
Peripheral arterial vascular disease 9
Vascular neurologic disease 6
Previous AMI 2
HF history 7
Previous PTCA 2
AF 5
Anemia 30
CCS class III 9
CCS class IV 4
NYHA class III 10
NYHA class IV 7
LVEF (%)  SD 50%  14.2
LVEF ≤35% 8
Urgent operation 9
Emergent operation 4
COPD, chronic obstructive pulmonary disease; AMI, acute myo-
cardial infarction; HF, heart failure; AF, atrial ﬁbrillation; LVEF, left
ventricular ejection fraction.
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disease [4], because they have a greater incidence of systemic
hypertension, diabetes mellitus and dyslipidemia. Patients with
ESRD have an acceptable prognosis after open heart surgery
procedures. In the literature, the reported hospital mortality for
these patients has ranged between 0% and 36% [5–11].
Although there has been tremendous advancement in the
use of percutaneous transluminal coronary angioplasty (PTCA)
for the treatment of coronary artery disease, coronary artery
bypass grafting (CABG) remains the gold standard for
revascularization [12]. There is a question if off-pump
coronary artery bypass (OPCAB) surgery is potentially attrac-
tive for patients likely to have severe vasculopathy, such as
patients with ERDS. Its principal physiologic advantages over
on-pump CABG surgery include the ability to avoid the
deleterious consequences of systemic inﬂammatory response
initiated by the cardiopulmonary bypass [13] and thromboem-
bolism caused by aortic cannulation and crossclamping [14]. In
our institution we usually perform the OPCAB procedure
depending on patient's hemodynamic stability. This is usually
problem in patients who are undergoing the urgent or
emergent procedure.
The meta-analysis focused on valve replacement in
patients with ESRD on dialysis has shown that there no
difference was observed in survival between the valve types
(bioprostheses versus mechanical prostheses) [15]. But bio-
prostheses valve replacement is associated with fewer valve-
related complications. The choice of valve in the patients with
ESRD should be determined by age, level of activity and patient
choice. There is no sufﬁcient evidence to recommend
mechanical or tissue valves. Due to the limited life expectancy
of these patients, bioprosthetic valves should be considered
especially since there is no evidence of early degeneration of
tissue valves in this subgroup of patients [16].
The goal of this study was to evaluate perioperative and
mid-term results of cardiac surgery procedures in patients
with ESRD.
Materials and methods
We retrospectively reviewed the data of 36 dialysis-dependent
patients (14 women and 22 men) who underwent heart surgery
between 2008 and 2013 at our institution. Mean patient age at
the time of surgery was 63  9.4 years (range 44–80). Mean
preoperative duration of dialysis was 4.8  6.3 years (range 0.5–
12 years). Preoperative mean creatinine level was 58.8
 275 mmol/l (range 200–1019 mmol/l). And preoperative mean
potassium level was 4.9  1.6 mmol/l (range 3.12–6.88 mmol/l).
All the patients underwent dialysis on the day prior to
surgery and on the ﬁrst postoperative day after hemodynamic
stabilization.
Emergent operation was deﬁned as in the case of an
operation performed within the same working day of the
consultation or within 24 h after consultation. Urgent opera-
tion was deﬁned as an unscheduled operation performed
within 72 h after consultation.
Heart surgery was performed using cardio-pulmonary
bypass (CPB) in 16 patients (44%), while the others 20 patients
were operated off-pump. On-pump operations were supportedwith intraoperative hemoﬁltration during CPB time if it was
necessary. Antegrade cold blood or cold crystalloid intermit-
tent cardioplegia was used at the discretion of the operating
surgeon. Off-pump beating heart revascularization was
performed always if it was possible depending on patient's
hemodynamic stability.
CABG-related myocardial infarction was deﬁned as the
evidence of cardiac biomarker values more than ﬁve times the
99th percentile of the normal reference range during the ﬁrst
72 h following CABG, when associated with appearance of new
pathological Q-waves or new left-bundle branch block, or
angiographically documented new graft or native coronary
artery occlusion, or imaging evidence of new loss of viable
myocardium.
Cerebrovascular accident was deﬁned as any neurological
deﬁcit longer than 24 h conﬁrmed by clinical ﬁndings or
computed tomographic scan.
Bleeding was determined as a re-exploration owing to
excessive mediastinal bleeding or cardiac tamponade.
Respiratory failure was determined as a requirement for
mechanical ventilatory support for more than 2 days after
surgery in the ICU.
In-hospital mortality was considered to be any death
occurring within 30 days after surgery (Table 1).
Results
We identiﬁed 36 patients on hemodialysis who underwent the
cardiac surgery during the 5-year period 2008–2013.
Twenty-one (58.3%) patients underwent isolated CABG
surgery, eight (22.2%) underwent combined CABG plus valve
Table 3 – Postoperative complications.
Complication Number of
patients
Heart failure 4
Postoperative AMI 3
Postoperative bleeding and cardiac tamponade 3
Deep sternal wound infection 3
Infection of wound after saphenous vein harvesting 4
Stroke 2
AF 6
Post-pericardiotomy syndrome 3
AMI, acute myocardial infarction; AF, atrial ﬁbrillation.
Table 2 – Operative procedures.
Procedure Number of patients
Isolated CABG 21
AVR 1
MVR 1
AVR + CABG 3
MVP + CABG + MAZE 3
MVR + CABG 2
AAR 1
Others 4
Total 36
AVR, aortic valve replacement; MVR, mitral valve replacement;
MVP, mitral valve plasty; AAR, aortic arch replacement.
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surgery. In patients operated n for coronary revascularization,
the left internal mammary artery was anastomosed in 12
(33.3%) patients. In total, we implanted ﬁve valves (one
mechanical and four biological), respectively four in aortic
position and only one in mitral position. The other procedures
on valves surgery were annuloplastics (one mitral annulo-
plasty and one tricuspidal). Mean CPB time was 109.72
 46.03 min and mean aortic cross clamping time was 69.6
 30.2 min. Operative details are reported in Table 2.
30-Day mortality rate was 11.1% (four patients). All these
patients underwent the urgent procedure. Causes of death
were cardiac related in one patient (acute myocardial infarc-
tion after surgery). Two deaths occurred in patients who
underwent cardiac surgery procedure on pump (ascending
aorta replacement and infected thrombus removing), one
death occurred in patient who underwent suture of injured
right ventricle and another one death occurred in a patient
who underwent the conventional myocardial revasculariza-
tion.
The overall mean follow-up was 37.6  12.3 months. There
were 8 (22.2%) deaths during the ﬁrst year follow-up and 11
deaths (30.5%) during the total follow-up period. The cause of
death was refractory heart failure in four cases, multiple organ
dysfunction syndrome (MODS) with sepsis in four patients,
stroke in two patients and acute bilateral pneumonia in one
patient. In the group of patients that underwent revasculari-
zation with OPCAB, there were no perioperative deaths. In the
group of patients who underwent revascularization with use
CPB, there was one perioperative death, and the operative
mortality was 9.1% in this subgroup of patients. Six of alldeaths (54.5%) occurred in patients who underwent the urgent
or emergent procedure.
Other postoperative complications are reported in Table 3.
Discussion
ESRD is one of the most principal factor predictive mortality
and morbidity after heart surgery procedures. Most patients
affected by ESRD had left ventricular hypertrophy secondary to
systemic arterial hypertension, hyperparathyroidism second-
ary to chronic renal disease, and the other systemic comor-
bidities such as peripheral and cerebrovascular disease and
diabetes. All these factors can lead to accelerated atheroscle-
rosis and calciﬁcations of coronary arteries and heat valves
[5,17].
The in-hospital mortality in these patients is reported to
range from 0 to 36.7% [5–11]. Our experience conﬁrms these
ﬁndings, with an in-hospital mortality rate of 11.1%. The
highest mortality rate is reported in patients who underwent
valve procedures or combined surgery [18]. The severity of
heart valve disease in dialysis-dependent patients can be
underestimated because the onset of symptoms such as
congestion and effusion can be hidden by dialysis.
Heart surgery in dialysis-dependent patients is associated
with signiﬁcant postoperative complications such as periop-
erative low cardiac output syndrome, tendency to bleeding,
high infections rate, stroke and respiratory failure [5,19].
Review of literature suggests that sepsis and intra-abdominal
complications occur at a high rate in patients with ESRD
undergoing cardiac surgery [5,20].
Reoperation for bleeding was an uncommon problem in our
series. It occurred in three patients (8.6%). Homeostasis
disturbances, platelet dysfunction, coagulation defects
depending on uremia, and mechanical stress of blood cells
during dialysis can all be co-factors increasing postoperative
bleeding in these patients. Careful hemostasis management
and the use of antiﬁbrinolytic agents can minimize this
perioperative complication.
Infections are common in dialysis-dependent patients
because of decreased function of immune system and steroid
therapy for autoimmune causes of ERDS. In our experience, we
reported a higher incidence in postoperative infection rates in
this group of patients. Three patients had deep sternal wound
infection which required other therapy. Other four patients
suffered from infection of wound after harvesting of saphe-
nous vein. No mediastinitis was detected in our series.
Off-pump CABG has become another option in the
treatment of patients with coronary artery disease, especially
those with associated systemic disease, functional im-
pairment of various organs, and in patients with technical
obstacles to on-pump surgery due to severe aortic calciﬁca-
tions [21,22]. On the other hand, coronary artery disease is
often very severe and characterized by diffuse calciﬁcations
compared to population without ESRD, making off-pump
multivessel complete revascularization is very difﬁcult. A
study published by Kleisli et al. [23] has conﬁrmed that
complete revascularization improves long-term cardiac sur-
vival and functional status. Performing a coronary anastomo-
sis in beating heart technique without using CPB remains a
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reached on the possibility to perform a complete revasculari-
zation with off-pump technique, the beating heart coronary
artery surgery can be realized with stable success only in the
hands of an experienced surgeon.
Controversy persists with regard to the optimum choice of
prosthesis for valve replacement in patients with ESRD.
Bioprosthesis valve degeneration has been reported as a
consequence of a multitude of mineral metabolism abnor-
malities, but higher thromboembolism and bleeding rates and
valve related morbidity have been reported with mechanical
valve prosthesis [6]. Herzog et al. [24] compared the long-term
survival after heart valve replacement with mechanical and
biological prosthetic valves. They found out similar 2-year
survival rates in both groups of patients. Their ﬁndings suggest
that the life expectancy is poor and should not affect the
prosthesis choice. Nicolini et al. [18] reported that the most of
patients receiving mechanical prostheses, strokes were
documented as the cause of death in minimal rates of
patients, conﬁrming the results of the other groups. They
usually perform valve replacement using mechanical pros-
theses in patients ≤65 years old affected by aortic valve
disease, in patients ≤70 years old with mitral valve disease,
and in patients with atrial ﬁbrillation, irrespective of age. They
recommended biological prostheses for dialysis-dependent
patients who are elderly or affected by systemic comorbidities
or coagulopathies. The new generation of bioprostheses could
be evaluated for a wider use in these high-risk patients, due to
their slow degeneration rate. In patients receiving biological
prostheses, after short period of oral anticoagulation, antith-
rombotic prophylaxis can be obtained with aspirin, as
demonstrated other studies [25].
Long-term survival of dialysis-dependent patients after
cardiac surgery is decreased, as reported in the largest series
recently published. Bechtel et al. [26] found 42% survival
probability at 5 years. Nicolini et al. [18] reported 72% 5-year
survival rates. The history of preoperative heart failure and the
complexity of the surgical procedures (valve surgery, com-
bined CABG + valve and major aortic surgery) were identiﬁed
as predictors of increased mortality.
The limitations of this study should be noted. This series
reported a single center experience with a relatively small
number of patients and the operations included elective
surgery in the most of cases. This was a retrospective and
observational study, and therefore any conclusions are limited
in their application.
In conclusion, the perioperative risk of dialysis-dependent
patients is higher than normal, but not prohibitive, and good
candidates for surgery can be identiﬁed. CABG can be
performed with good early and late results. However, in this
subgroup of patients, a rigorous post-operative medical
therapy based on antiaggregants and statins appears manda-
tory, because it is well known that these drugs counteract the
development and progression of atherosclerosis and chronic
inﬂammation and support the late patency of the grafts [27].
Dialysis-dependent patients affected by cardiac valve
diseases should undergo a cardiological screening at short-
term intervals using non-invasive techniques such as echo-
cardiography to detect worsening in heart function prior to
decompensation. In this setting, close collaboration ofnephrologists, cardiologists and surgeons appears mandatory,
because surgical results can be improved in dialysis-depen-
dent patients affected by valve lesions associated with or not
coronary artery disease only be an early referral to surgery.
In conclusion, patients with ESRD are at a high risk of
cardiovascular diseases and cardiac complications, resulting
in higher rates of mortality than in the general population.
Heart surgery in these patients is associated with higher rates
of postoperative complications. Our outcomes of the cardiac
surgery procedures in patients with ESRD are acceptable.
Optimization of perioperative management and clinical
outcome of patients with ESRD can improve with the better
understanding of the associated risk factors. This could help in
timely referral to the cardiac surgeon, thus reducing the
perioperative risk.
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